Follow us on:
Breaking News
August 31, 2026
Breaking News
Breaking News
Featured eBook Release
Sartorius_BrandedContent_0726_FeaturedContent

Lilly to Acquire Merida Biosciences for $2.875B

 
Lilly to Acquire Merida Biosciences for $2.875B

Merida’s lead program is in Phase I development for Graves’ disease and thyroid eye disease.
Read More >>

Headlines

Breaking News
Collaborations & Alliances

RedHill Biopharma Divests Talicia Stake to Apotex Subsidiary for $18M

Apotex previously absorbed a 30% stake in Talicia through its acquisition of Cumberland Pharmaceuticals’ U.S. business.

SPONSOR

Sterile Injectable Development Getting Harder? Here's Your Playbook

Tighter timelines, complex molecules, and supply risk are reshaping sterile drug development. This free eBook covers formulation, fill and finish readiness, delivery, and cold chain planning. Download now.

Breaking News
Trials & Filings

FDA Approves Gilead’s Bixlenvo, Once-Daily Pill for Virologically Suppressed Adults with HIV

Bixlenvo becomes the first, and smallest, once-daily single-tablet regimen available.

Breaking News
Collaborations & Alliances

DualityBio and Genentech to Develop Next-Gen ADCs on Novel Payload Platform

Genentech will have license exclusivity, while DualityBio will lead discovery and early clinical development.

SPONSOR

Commercial Geography is a Strategic Variable

Inspection history, trade exposure, and geographic alignment now define commercial readiness. Read the May cover feature.

FederalEquipment_eBook_0326_650x250

Breaking News
Promotions & Moves

Alto Neuroscience Promotes Nick Smith to President and CFO

Smith will continue leading finance while overseeing corporate strategy and business development.

SPONSOR

Pharmaceutical Formulation 2026: Patient-Centric, Personalized, and Powered by Innovation

Learn how advanced science, digital design, and collaborative CDMOs are redefining the future of drug delivery.

Featured Resources

Solution Content Center SPOTLIGHT

Eagle Analytical

Eagle is an FDA- and DEA-registered, A2LA ISO 17025-accredited CGMP laboratory providing analytical, microbiological, consulting, and technical services. From our 80,000+ sq. ft. state-of-the-art facility, we support compliance and quality assurance needs from raw materials to finished products.

 

Solution Content Center SPOTLIGHT

Ropack Pharma Solutions

Ropack Pharma Solutions, celebrating 50 years, specializes in solid oral dose formats for pharmaceutical, nutraceutical, and food products. We provide comprehensive manufacturing, packaging, and clinical trial services, delivering trusted, innovative solutions that help our partners bring key products to market.